Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Grown Rogue International Inc. (GRUSF) Form 8-K — Aug 25, 2026

$GRUSFForm 8-KItems 1.01, 3.02, 7.01, 9.01Filed Aug 25, 2026, 3:50 PM ET0001279569-26-000827Original filing

Grown Rogue International filed an 8-K (Items 1.01, 3.02, 7.01, 9.01) disclosing definitive agreements to enter the New York cannabis market through the planned acquisition of PharmaCann's New York license and assets via Grown Rogue New York LLC, a 51/49 joint venture with a capital partner. The deal preserves PCNY's operations ahead of definitive purchase agreements expected within roughly four weeks.

Key figures

Debt Amount
up to $15 million total project-based financing: $10 million preferred equity plus a $5 million drawable 15% term loan; additionally up to $9 million secured loan from GRNY to PCNY
Deal Value Usd
approximately $4.5 million anticipated purchase price for PCNY license and assets (including inventory adjustment), within ~$12 million estimated total project costs
Interest Rate
15
Warrant terms
0.901 warrants per dollar drawn at $0.55 exercise price, five-year term
Production ramp
six-to-nine months
Conversion prices
$0.55 through third anniversary, then $0.65 and $0.76
Conversion shares
approximately 18.2 million subordinate voting shares
Secured loan to pcny
up to $9 million
Commitment fee shares
300000
Prior flower production
more than 2,000 lbs per month before early 2026 slowdown
Total project financing
up to $15 million
Potential dilution percent
approximately 7%
Cash flow positive timeline
within nine months (management expectation)
Preferred equity investment
$10 million for 49% preferred equity interest in GRNY
Anticipated annual cost savings
approximately $20 million
Hamptonburgh indoor canopy sqft
24000
Monthly dispensary sales history
$1.7-2.0 million aggregate over past 18 months
Hamptonburgh greenhouse canopy sqft
16000
Capital partner priority distribution
$1 million year one, $2 million annually thereafter
Purchase price payable on regulatory approval
$3 million
Expected monthly after tax cash flow within 18 months
approximately $600,000

AI analysis

Red flags8 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.